19 studies found for:    " November 14, 2007":" December 14, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" November 14, 2007":" December 14, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (19 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Cell Transfer
2 Completed
Has Results
Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: buprenorphine;   Other: Clinical evaluations/Blood draws
3 Completed Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their Children
Condition: HIV Infections
Interventions: Dietary Supplement: Meat Biscuit;   Dietary Supplement: Soy Biscuit;   Dietary Supplement: Wheat Biscuit
4 Completed HIV-HCV Coinfection: Impact of Immune Dysfunction
Conditions: HIV Infections;   Hepatitis
Intervention:
5 Completed CDC HIV Testing Guidelines: Unresolved Ethical Concerns
Condition: HIV Infections
Intervention: Other: CDC HIV testing recommendations
6 Completed Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
7 Unknown  Energy Specific Far Infrared Radiation Treatment for AIDS
Condition: HIV Infections
Intervention: Radiation: Far infrared
8 Completed Effect of HIV/STD Risk Reduction Program on South African Adolescents
Conditions: HIV Infections;   Sexually Transmitted Disease
Interventions: Behavioral: HIV/STD Risk-Reduction;   Behavioral: Health Promotion
9 Active, not recruiting Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
Conditions: HIV Infections;   Atherosclerosis
Intervention:
10 Unknown  Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
Conditions: HIV Infections;   Hypertension
Interventions: Drug: candesartan;   Drug: lercanidipine
11 Completed Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
Condition: HIV Infections
Intervention: Drug: Tenofovir gel
12 Completed Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
Condition: HIV Infections
Interventions: Drug: Tenofovir/Emtricitabine (Truvada) and Nevirapine;   Drug: Tenofovir/Emtricitabine/Efavirenz (Atripla);   Drug: Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia);   Drug: Tenofovir/Emtricitabine (Truvada) and Zidovudine
13 Withdrawn Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART
Conditions: HIV Infections;   Hyperlipidemia;   Exercise
Intervention: Dietary Supplement: l-carnitine
14 Unknown  Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Placebo
15 Completed Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population
Condition: HIV Infections
Intervention:
16 Completed
Has Results
VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients
Condition: HIV Infections
Interventions: Drug: nevirapine IR;   Drug: nevirapine XR
17 Completed Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults
Condition: HIV Infections
Interventions: Biological: Pneumococcal vaccines + CPG 7909;   Biological: Pneumococcal vaccines
18 Active, not recruiting Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma
Condition: Lymphoma
Interventions: Biological: lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Procedure: autologous hematopoietic stem cell transplantation
19 Completed Continuous Use of COCs
Condition: Pregnancy Prevention
Intervention: Drug: Oral contraceptives--ethinyl estradiol, levonorgestrel

Indicates status has not been verified in more than two years